If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,919.00    -21.00 (-1.08%)
Bid:
1,926.00
Ask:
1,928.00
Spread: 2.00 (0.104%)
Market Cap: £3.77b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Stabilisation Notice

13 Nov 2015 07:00

RNS Number : 5941F
Softcat PLC
13 November 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

13 November 2015

 

Softcat plc

 

Stabilisation Notice

 

 

Jefferies International Limited (contact: Lee Morton; telephone: +44 (0)20 7029 8753, Luca Erpici; telephone: +44 (0)20 7029 8415) hereby gives notice that it, and its affiliates, may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

 

Issuer:

 

Softcat plc

Shares:

 

Ordinary Shares of £0.0005 each in the capital of Softcat plc (ISIN: GB00BYZDVK82)

 

Offer size:

 

63,919,956 Ordinary Shares

Offer price:

 

240 pence per Ordinary Share

Stabilisation:

 

Stabilising Manager:

 

Jefferies International Limited, Vintners Place, 68 Upper Thames Street, London EC4V 3BJ

 

Stabilisation period expected to start on:

 

8:00am on 13 November 2015

Stabilisation period expected to end no later than:

 

11 December 2015

Maximum size of over-allotment facility:

 

9,587,993 Ordinary Shares

Over-allotment Option:

 

Terms:

The Over-allotment Shareholders have granted to Jefferies International Limited, in its capacity as stabilising manager, the option to acquire up to an additional 9,587,993 Ordinary Shares (representing 15% per cent. of the Ordinary Shares to be sold by Selling Shareholders in the offer) at the offer price.

 

Duration:

This option may be exercised by the Stabilising Manager in whole or in one or more parts, on one or more occasions at any time from 13 November 2015 to 11 December 2015.

 

 

Jefferies International Limited ("Jefferies") is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting on behalf of Softcat plc and no one else in connection with the offer and will not be responsible to any person other than Softcat plc for providing the protections afforded to any of their clients or for providing advice in relation to the offer.

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting, stabilising or maintaining the market price of the securities at a level higher than that which might otherwise prevail in the open market. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time without prior notice. Any stabilisation action shall be carried out in accordance with all applicable rules and regulations.

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

 

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States (including its territories and possessions, any State of the United States and the District of Columbia). This announcement is for informational purposes only and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act") or under the securities laws of any state or other jurisdiction of the United States.

 

The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act. There will be no public offer of securities in the United States.

 

This announcement and copies of this announcement are not being made and may not be distributed, published, or sent, directly or indirectly, in whole or in part, in or into Australia, Canada, Japan, South Africa or to any persons in any of those jurisdictions or any other jurisdictions where to do so would be unlawful or would require registration or other measures.

 

The offer and the distribution of this announcement and other information in connection with the listing and offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement, any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not and does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in Australia, Canada, Japan, South Africa or any other jurisdiction where such an offer would be unlawful.

 

The securities referred into herein have not been and will not be registered under the applicable securities laws of Canada, Japan, South Africa or Australia and may not be offered or sold in Australia, Canada, Japan or South Africa except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the applicable securities laws. There will be no public offering of securities in Australia, Canada, Japan or South Africa.

 

This announcement is only addressed to, and directed at, persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Directive" means Directive 2003/71/EC (as amended) and includes any relevant implementing measure in each member state of the European Economic Area which has implemented the Prospectus Directive. In addition, in the United Kingdom, this announcement is being distributed only to, and is directed only at, Qualified Investors (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who are high net worth companies, unincorporated associations and partnerships and trustees of high value trusts or other persons to whom it may otherwise lawfully be communicated falling within Article 49(2)(a)-(d) of the Order, (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this announcement relates is available only to and will only be engaged in with such persons. This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not relevant persons; and (ii) in any member state of the European Economic Area other than the United Kingdom, by persons who are not Qualified Investors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAUUOURVKAAAUA
Date   Source Headline
10th Feb 20252:37 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20251:55 pmRNSDirector/PDMR Shareholding
20th Jan 20259:34 amRNSHolding(s) in Company
17th Jan 20253:51 pmRNSDirector/PDMR Shareholding
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:52 amRNSTotal Voting Rights
12th Dec 20243:07 pmRNSDirector/PDMR Shareholding
10th Dec 20243:40 pmRNSDirector/PDMR Shareholding
10th Dec 202412:54 pmRNSResult of AGM
4th Dec 20242:22 pmRNSDirector/PDMR Shareholding
2nd Dec 202412:11 pmRNSTotal Voting Rights
26th Nov 202410:47 amRNSDirector/PDMR Shareholding
26th Nov 202410:45 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSQ1 2025 Trading Update
18th Nov 20241:55 pmRNSBlock listing Interim Review
11th Nov 20243:31 pmRNSDirector/PDMR Shareholding
1st Nov 20242:36 pmRNSAnnual Financial Report
1st Nov 20249:19 amRNSTotal Voting Rights
24th Oct 20247:00 amRNSFinal Results
14th Oct 202410:01 amRNSHolding(s) in Company
8th Oct 20243:06 pmRNSDirector/PDMR Shareholding
7th Oct 20242:28 pmRNSNotice of Results
1st Oct 20242:37 pmRNSTotal Voting Rights
26th Sep 20249:34 amRNSHolding(s) in Company
16th Sep 20249:41 amRNSHolding(s) in Company
13th Sep 202410:21 amRNSHolding(s) in Company
11th Sep 20249:26 amRNSDirector/PDMR Shareholding
22nd Aug 20249:30 amRNSHolding(s) in Company
9th Aug 202410:45 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSTotal Voting Rights
24th Jul 20249:32 amRNSHolding(s) in Company
9th Jul 202412:29 pmRNSDirector/PDMR Shareholding
1st Jul 20249:17 amRNSTotal Voting Rights
10th Jun 202412:53 pmRNSChange of Adviser
10th Jun 202411:24 amRNSDirector/PDMR Shareholding
3rd Jun 20249:26 amRNSTotal Voting Rights
28th May 20247:00 amRNSQ3 2024 Trading Update
23rd May 202410:02 amRNSBlock listing Interim Review
10th May 20242:25 pmRNSDirector/PDMR Shareholding
9th May 20243:09 pmRNSDirector/PDMR Shareholding
1st May 202410:50 amRNSTotal Voting Rights
9th Apr 20249:45 amRNSDirector/PDMR Shareholding
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20241:00 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSHalf-year Report
15th Mar 20242:45 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSNotice of Results
1st Mar 20242:28 pmRNSHolding(s) in Company
1st Mar 202410:47 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.